Characterization of GLP-1 Effects on β-Cell Function After Meal Ingestion in Humans

GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MAN

1987 • 1,845 citations

The Glucagon-Like Peptides

1999 • 1,018 citations

Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes Mellitus

1992 • 858 citations

Estimation of Insulin Secretion Rates from C-Peptide Levels: Comparison of Individual and Standard Kinetic Parameters for C-Peptide Clearance

1992 • 804 citations

Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans

1997 • 799 citations

Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo.

1995 • 741 citations

Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance

1992 • 612 citations

The Influence of GLP-1 on Glucose-Stimulated Insulin Secretion

2003 • 566 citations

Biological actions and therapeutic potential of the glucagon-like peptides

2002 • 496 citations

Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.

1993 • 467 citations

Meal and oral glucose tests for assessment of β-cell function: modeling analysis in normal subjects

2002 • 296 citations

Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal.

1994 • 283 citations

Insulinotropic Action of Glucagonlike Peptide-I-(7–37) in Diabetic and Nondiabetic Subjects

1992 • 282 citations

GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans

1999 • 277 citations

Assessing Insulin Secretion by Modeling in Multiple-Meal Tests

2002 • 238 citations

Glucagon-Like Peptide-1

2001 • 161 citations

Glucagon-like peptide-1 (GLP-1): A gut hormone of potential interest in the treatment of diabetes

1998 • 124 citations

Normalization of Insulin Responses to Glucose by Overnight Infusion of Glucagon-Like Peptide 1 (7–36) Amide in Patients With NIDDM

1996 • 115 citations

Potential Therapeutic Levels of Glucagon-Like Peptide I Achieved in Humans by a Buccal Tablet

1996 • 95 citations

An alternate pathway of cAMP-stimulated Cl− secretion across the NKCC1-null murine duodenum

2002 • 94 citations

GLP-1 Tablet in Type 2 Diabetes in Fasting and Postprandial Conditions

1997 • 80 citations

Amplification of exocytosis by Ca²⁺‐induced Ca²⁺ release in INS‐1 pancreatic β cells

2003 • 75 citations

Fasting blood glucose in determining the prevalence of diabetes in a large, homogeneous population of Caucasian middle‐aged women

1995 • 46 citations

Antidiabetogenic action of glucagon‐like peptide‐1 related to administration relative to meal intake in subjects with type 2 diabetes

2001 • 25 citations